Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results

BACKGROUND AND AIM: Long-term treatment with tenofovir disoproxil fumarate (TDF) has demonstrated suppression of viral replication outside of China. This study aims to assess efficacy, resistance and safety of TDF for up to 240 weeks in Chinese patients with chronic hepatitis B virus (HBV) infection...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hepatol Int
Asıl Yazarlar: Liang, Xieer, Gao, Zhiliang, Xie, Qing, Zhang, Jiming, Sheng, Jifang, Cheng, Jun, Chen, Chengwei, Mao, Qing, Zhao, Wei, Ren, Hong, Tan, Deming, Niu, Junqi, Chen, Shijun, Pan, Chen, Tang, Hong, Wang, Hao, Mao, Yimin, Jia, Jidong, Ning, Qin, Xu, Min, Wu, Shanming, Li, Jun, Zhang, Xinxin, Zhang, Wenyan, Xiong, Cui, Hou, Jinlin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer India 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6529393/
https://ncbi.nlm.nih.gov/pubmed/30977033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-019-09943-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller